Padlock Therapeutics Financial Analyst Salary | Comparably
Padlock is developing medicines targeting PADs, immune complexes in autoimmune diseases, and more. read more
EMPLOYEE
PARTICIPANTS
3
TOTAL
RATINGS
95

Padlock Therapeutics Financial Analyst Salary

The average Padlock Therapeutics Financial Analyst earns an estimated $74,237 annually, which includes an estimated base salary of $68,643 with a $5,594 bonus. Padlock Therapeutics' Financial Analyst compensation is $13,163 less than the US average for a Financial Analyst. Financial Analyst salaries at Padlock Therapeutics can range from $60,000 - $130,000.

The Finance Department at Padlock Therapeutics earns $13,274 more on average than the Admin Department.

Last updated 5 years ago.

$22k
$41k
$62k
$82k
$180k
$310k
$375k
$74,237
Average Compensation
$68,643
avg. base
$5,594
avg. bonus

Financial Analyst Salaries at Padlock Therapeutics

Financial Analysts earn $3,668 more than Accountants, and $56 less than Financial Analysts.

Accounting Manager
$118k*
Business Analyst
$91k*
Senior Accountant
$80k*
Financial Analyst
$74k*
Accountant
$71k*
* estimated salary

Compensation at Padlock Therapeutics by Department

The Finance Department averages $13,274 more than the Admin Department, and $190 less than the Operations Department

Operations
$72,483 Avg. total comp.
+$190
Finance
$72,293 Avg. total comp.
Admin
$59,019 Avg. total comp.
-$13k

Financial Analyst Compensation by Gender (All Companies)

The average female Financial Analyst at companies similar size to Padlock Therapeutics reported making $93,556, while the average male Financial Analyst at similar sized companies reported making $91,853.

Financial Analyst Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Financial Analyst at companies similar size to Padlock Therapeutics reported making $98,729, while the average Native American Financial Analyst at similar sized companies reported making $60,000.

How Financial Analysts at Padlock Therapeutics Rate Their Compensation

The majority of Financial Analysts at Padlock Therapeutics believe they're compensated fairly. 50% of Financial Analysts at Padlock Therapeutics say they receive annual bonuses, and the vast majority (100%) are satisfied with their benefits. See more compensation ratings at Padlock Therapeutics

×
Rate your company